Gestational diabetes mellitus is an increasingly frequent metabolic disorder that is important for both baby and mother. New studies on the development and treatment of the disease are required. In this study was aimed to investigate the effects on offspring's survival and biochemical values of diabetes mellitus induced using different doses of two chemical agents among 35 rats with advanced pregnancy. The rats were randomly divided into five groups, with the rats in group 1 as controls.
INTRODUCTION
Hyperglycemia and hyperketonemia have been observed to cause fetal malformations in experiments conducted with rats. In these tests, the malformation rate was 20% when the glucose level was two-fold higher than the control level and 50% when the glucose level was 4-fold higher than the control level (1-3).
Diabetes may be induced using surgical, pharmacological or genetic methods in various types of animals. Rats are currently the most commonly used test animal model (4) (5) (6) .
A pharmacological induction model has been used to induce diabetes in most studies.
Streptozotocin and alloxan are the most commonly used chemicals. These substances exert their diabetic effect after injection via the intraperitoneal, intravenous and subcutaneous routes. The dose of the agents varies depending on type of animal and the administration route of the agents (7, 8) . In diabetes studies, rats with fasting plasma glucose levels above 250 mg/dl are accepted as diabetic (9) .
Hypoinsulinemia syndrome induced by streptozotocin is defined as streptozotocin diabetes. Diabetes is accepted to develop on the same day as streptozotocin administration (10) . Alloxan is a selective agent that damages pancreatic beta cells. Pancreatic beta cells specifically take up alloxan, leading to the accumulation of this agent inside the cell (7).
The present study aimed to determine the influence of gestational diabetes induced using different chemical agents on newborns.
MATERIALS AND METHODS

Animals
In this study, 35 female Wistar albino rats weighing 200-250 grams and aged 3-4 months were used as the animal model. The animals were provided by the Fırat University Experimental Research Unit. During the study, the animals received a 12-hour day and night cycle. Food and water were provided ad libitum. Ethics committee approval was obtained from the Fırat University Test Animals Ethics Committee (FÜHADEK 2013/07-96).
Vaginal irrigation
Vaginal irrigation was applied as described by Risvanli et al. (11) .
Application groups
On day 13 of pregnancy, the animals were grouped as follows: Group 1 was the control group and received intraperitoneal saline solution (n=7); Group 2 received 40 mg/kg of alloxan (Sigma) intraperitoneally (n=7) (12) ; Group 3 received 60 mg/kg of alloxan (Sigma) intraperitoneally (n=7) (12); Group 4 received 40 mg/kg of streptozotocin (Sigma) intraperitoneally (n=7) (13); and Group 5 received 60 mg/kg of streptozotocin (Sigma) intraperitonally (n=7) (13) .
Blood was drawn from the tails of the animals on day 3 of injections, which corresponded to day 16 of gestation, and glucose concentrations were measured using a glucometer. While a normal plasma glucose value was accepted as 90-110 mg/dl, animals with plasma glucose levels above 250 mg/dl were accepted as diabetic (9) .
Analyses
When the offspring were one month of age, one healthy female offspring of each animal was decapitated. Blood was drawn from the decapitated animals, and sera were separated following routine procedures and stored at -20°C until the day of measurements.
Glucose, total protein, albumin, triglyceride, cholesterol, Ca and P levels were measured, and inter-group comparisons were made. The measurements were made using the spectrophotometric method.
Statistical analysis
The Kruskal Wallis test was utilized to compare the duration of pregnancy and serum glucose, total protein, albumin, triglyceride, cholesterol, Ca and P levels between the groups.
The Mann Whitney U test was used to determine the significance level. The Qui-square test was applied to determine the survival rates. The statistical analyses were performed using the SPSS 11.5 software program.
RESULTS
The mean plasma glucose concentrations of the mother rats on day 16 of pregnancy are presented in Table 1 . One animal in each of groups 2, 3, and 5 died after the injections. One animal in each of groups 2 and 3 had abortions (Table 2) .
Blindness was observed in one offspring born to the rats in group 4. No anomalies were observed in the other groups ( Table 2 ).
The inter-group comparisons revealed that the duration of pregnancy was shorter in the control group (i.e., Group 1) than in the experimental groups (21.00±0.31 days) and that diabetic agents administered at different doses prolonged the duration of pregnancy (P<0.05) ( Table 2) .
When the groups were compared with respect to survival rates, death was most commonly observed in the alloxan groups (30 number in group 2 and 27 number in group 3) (P<0.01) ( Table 2 ). In the streptozotocin-treated groups, the number of offspring mortality was higher (7 in group 4 and 4 in group 5) than that of the control group but lower than that of the alloxan groups (P<0.01) ( Table 2 ).
The biochemical parameters of the offspring are summarized in Table 3 . However, no differences in serum glucose, total protein, albumin, triglyceride, cholesterol, Ca and P values were observed between the groups (P>0.05).
DISCUSSION
Some fetal and maternal complications are observed more frequently in pregnancies complicated with diabetes, and many pregnancies terminate in the early weeks due to these complications. In addition, unexplained fetal losses are observed at advanced weeks of gestation (14) (15) (16) . In the present study, different types of chemical agents were determined to cause changes in the survival of offspring. Fifty-seven rats in the alloxan-treated groups and 11 rats in the streptozotocin-treated groups died. One offspring died in the control group.
However, streptozotocin caused a smaller number of offspring mortality than alloxan.
Furthermore, in this study, a prolonged duration of pregnancy was observed and stillbirth, abortion, blindness and maternal death were observed more frequently in diabetic rats than in non-diabetic rats. The duration of pregnancy was shorter in the control group (i.e., Group 1) (21.00±0.31 days) than in the other groups, and diabetic agents applied at various doses prolonged the duration of pregnancy (P<0.05). High abortion rates were encountered in the treatment groups.
Congenital anomalies, which are observed at a rate of 1-2% in humans, are 4-to 8-fold more frequent among patients who have known pregestational diabetes; this condition is an important cause of mortality in diabetic pregnancies (17) (18) (19) . In animal studies, LopezSoldado and Herrera (20) reported that concerns streptozotocin-induced type 1 diabetic pregnancy that also leads to macrosomia in offspring. The streptozotocin, when administered at a high single dose at the advanced pregnancy induced a lot of genetic problem. But, low doses are less common for such problems (21) . In the present study, blindness was observed in only one offspring, which had received 40 mg of streptozotocin.
The rates of hypoglycemia, hypocalcemia, hyperbilirubinemia and polycytemia have been reported to increase during the newborn period in babies born to diabetic mothers (22, 23) . Van Assche et al (24) reported that animals with perinatal hyperinsulinemia display an impaired glucose tolerance at adulthood only under high glucose. In animal models, type 1 diabetic pregnancy in rats is associated with a significant increase triglyceride. In the present study, no differences in the serum glucose, total protein, albumin, triglyceride, cholesterol, Ca and P levels of female offspring born to diabetic rats with advanced pregnancy were detected.
In some previous studies streptozotocin could induce chronic diabetes in experimental animals. However, the some studies also noted streptozotocin that soon induced diabetes (20, 21, 24) . In present study, streptozotocin has established diabetes in a short time and only developing gestational diabetes of animals was included in the study.
In conclusion, these results indicate that the offspring of diabetic rats with advanced pregnancy were clinically affected. Various degrees of glucose intolerance were demonstrated to cause problems in pregnancy, as well as increased fetal, maternal and neonatal complications. In this study conducted using rats, no striking differences were encountered in the laboratory findings, except for a prolonged duration of pregnancy, anomalous deliveries, stillbirths and abortions in the treatment groups.
Based on these data, it is again suggested that streptozotocin could be used more effectively than alloxan to the studies on female offspring born from rats with gestational diabetes mellitus. Also it was found to not affect the results of dose streptozotocin. 
